William Osler Health System/Brampton Civic Hospital — Brampton, Ontario

Public research footprint of William Osler Health System/Brampton Civic Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Estrogen Receptor-Positive, HER2-Negative Locally Advanced or… · Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor… · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT06982521 — Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for… (Recruiting)
NCT06635824 — Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at William Osler Health System/Brampton Civic Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.